WO2017101887A1 - Composition pharmaceutique bénéfique pour la santé apportant une supplémentation en magnésium et présentant des effets anti-oxydants, et procédé de préparation de ladite composition pharmaceutique bénéfique pour la santé - Google Patents

Composition pharmaceutique bénéfique pour la santé apportant une supplémentation en magnésium et présentant des effets anti-oxydants, et procédé de préparation de ladite composition pharmaceutique bénéfique pour la santé Download PDF

Info

Publication number
WO2017101887A1
WO2017101887A1 PCT/CN2017/071165 CN2017071165W WO2017101887A1 WO 2017101887 A1 WO2017101887 A1 WO 2017101887A1 CN 2017071165 W CN2017071165 W CN 2017071165W WO 2017101887 A1 WO2017101887 A1 WO 2017101887A1
Authority
WO
WIPO (PCT)
Prior art keywords
magnesium
pharmaceutical preparation
hydrogen
preparation
healthcare
Prior art date
Application number
PCT/CN2017/071165
Other languages
English (en)
Chinese (zh)
Inventor
袁广银
裴佳
丁文江
Original Assignee
上海交通大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 上海交通大学 filed Critical 上海交通大学
Publication of WO2017101887A1 publication Critical patent/WO2017101887A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition pharmaceutique bénéfique pour la santé apportant une supplémentation en magnésium et présentant des effets anti-oxydants, ainsi qu'un procédé de préparation de ladite composition pharmaceutique bénéfique pour la santé. Cette composition pharmaceutique bénéfique pour la santé comprend un principe actif principal, qui est un agent à base de magnésium, et un excipient, l'agent à base de magnésium étant constitué d'une micro/nano-poudre de MgH2, l'excipient étant un excipient couramment utilisé dans les compositions pharmaceutiques.
PCT/CN2017/071165 2015-12-15 2017-01-13 Composition pharmaceutique bénéfique pour la santé apportant une supplémentation en magnésium et présentant des effets anti-oxydants, et procédé de préparation de ladite composition pharmaceutique bénéfique pour la santé WO2017101887A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510943741.8 2015-12-15
CN201510943741.8A CN105456288B (zh) 2015-12-15 2015-12-15 一种补镁兼具抗氧化作用的保健药品制剂及其制备方法

Publications (1)

Publication Number Publication Date
WO2017101887A1 true WO2017101887A1 (fr) 2017-06-22

Family

ID=55594753

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/071165 WO2017101887A1 (fr) 2015-12-15 2017-01-13 Composition pharmaceutique bénéfique pour la santé apportant une supplémentation en magnésium et présentant des effets anti-oxydants, et procédé de préparation de ladite composition pharmaceutique bénéfique pour la santé

Country Status (2)

Country Link
CN (1) CN105456288B (fr)
WO (1) WO2017101887A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110155942A (zh) * 2019-05-17 2019-08-23 上海镁源动力科技有限公司 一种基于氢化镁的缓释放氢制剂及其制备方法
CN114191409A (zh) * 2021-10-15 2022-03-18 张树刚 一种基于保健、抗癌、抗氧化、排毒的氢气胶囊
CN116458589A (zh) * 2023-04-21 2023-07-21 艾敕迩(东莞)氢能科技有限公司 一种氢气片制备用原材料配比工艺

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105456288B (zh) * 2015-12-15 2020-07-14 上海交通大学 一种补镁兼具抗氧化作用的保健药品制剂及其制备方法
CN108165395A (zh) * 2017-12-29 2018-06-15 上海交通大学 氢泡沫啤酒的制备方法
CN108041399A (zh) * 2017-12-29 2018-05-18 上海交通大学 氢泡沫软饮料的制备方法
CN113616671B (zh) * 2020-05-09 2022-06-28 上海交通大学 微纳米MgH2化合物颗粒在制备抑制利什曼原虫感染及治疗利什曼病药物中的应用
CN114948989A (zh) * 2021-02-19 2022-08-30 中国人民解放军海军军医大学 氢化镁在制备防治肾结晶结石病的药物中的应用
CN114948990A (zh) * 2021-02-22 2022-08-30 上海市肺科医院 氢化镁在制备防治急性呼吸窘迫综合征疾病药物中的应用
CN114452299A (zh) * 2022-02-10 2022-05-10 中国人民解放军火箭军特色医学中心 MgH2在制备治疗电离辐射导致的雄性生育能力损伤药物中的用途

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1225920A (zh) * 1998-02-10 1999-08-18 张经坤 氨基酸镁制备的方法及其应用
CN101742998A (zh) * 2007-03-22 2010-06-16 刘国松 镁组合物及其用途
CN103626669A (zh) * 2013-12-13 2014-03-12 四川生科力科技有限公司 甘氨酸镁螯合物的制备方法
JP2014064551A (ja) * 2012-09-26 2014-04-17 Techno Bank:Kk サプリメントキャンディ
CN105456288A (zh) * 2015-12-15 2016-04-06 上海交通大学 一种补镁兼具抗氧化作用的保健药品制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100554142C (zh) * 2006-08-04 2009-10-28 北京大学 氢化镁纳米颗粒及其制备方法和应用
EP2236144A1 (fr) * 2007-12-28 2010-10-06 MIZ Co., Ltd. Préparation externe pour utilisation préventive ou thérapeutique
US20130323190A1 (en) * 2011-02-17 2013-12-05 Hydrogen Health Medical Labo Co., Ltd. Composition generating hydrogen
CN102557227B (zh) * 2012-03-12 2013-10-09 彭振业 一种钙镁富氢水添加剂及其制备方法
CN102783691A (zh) * 2012-08-20 2012-11-21 李志林 一种钙镁制氢剂
DE102012217387A1 (de) * 2012-09-26 2014-04-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Therapeutische Nutzung von Wasserstoffmolekülen
CN104306398A (zh) * 2014-09-18 2015-01-28 宋忠慎 负氢离子抗氧化剂和锌、硼元素补充剂的低成本制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1225920A (zh) * 1998-02-10 1999-08-18 张经坤 氨基酸镁制备的方法及其应用
CN101742998A (zh) * 2007-03-22 2010-06-16 刘国松 镁组合物及其用途
JP2014064551A (ja) * 2012-09-26 2014-04-17 Techno Bank:Kk サプリメントキャンディ
CN103626669A (zh) * 2013-12-13 2014-03-12 四川生科力科技有限公司 甘氨酸镁螯合物的制备方法
CN105456288A (zh) * 2015-12-15 2016-04-06 上海交通大学 一种补镁兼具抗氧化作用的保健药品制剂及其制备方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110155942A (zh) * 2019-05-17 2019-08-23 上海镁源动力科技有限公司 一种基于氢化镁的缓释放氢制剂及其制备方法
CN114191409A (zh) * 2021-10-15 2022-03-18 张树刚 一种基于保健、抗癌、抗氧化、排毒的氢气胶囊
CN116458589A (zh) * 2023-04-21 2023-07-21 艾敕迩(东莞)氢能科技有限公司 一种氢气片制备用原材料配比工艺

Also Published As

Publication number Publication date
CN105456288A (zh) 2016-04-06
CN105456288B (zh) 2020-07-14

Similar Documents

Publication Publication Date Title
WO2017101887A1 (fr) Composition pharmaceutique bénéfique pour la santé apportant une supplémentation en magnésium et présentant des effets anti-oxydants, et procédé de préparation de ladite composition pharmaceutique bénéfique pour la santé
TW200942228A (en) Oral or enteral composition useful for recovery of physical functions
US11266169B2 (en) Composition for producing hydrogen rich water and other products
US20170209486A1 (en) Health-care preparation simultaneously with magnesium supplement and antioxidant functions and preparation method thereof
TW201034677A (en) Phosphate adsorbent
CN102626225B (zh) 一种具有增加骨密度和保护关节功能的保健食品及其制备方法
JP2022523513A (ja) 増強された硝酸塩組成物および使用法
WO2007109587A2 (fr) Compositions et procédés permettant de réduire l'inflammation et la douleur associées à l'acidose
US20180256640A1 (en) Magnesium-containing products and uses thereof
JP7461008B2 (ja) 脊髄損傷後の障害もしくは症状の予防又は治療剤
JP7461006B2 (ja) 関節炎の予防又は治療剤
CN107373274A (zh) 维生素c泡腾片及其制备方法
WO2001022943A1 (fr) Composition pharmaceutique a liberation lente
Newnham How boron is being used in medical practice
RU2527042C1 (ru) Биологически активная добавка к пище для профилактики заболеваний остеопорозом
CN107279865A (zh) 一种玛咖牡蛎食疗产品及其制备方法
WO2019119445A1 (fr) Composé nadh, formulation et application de celui-ci
US10485828B1 (en) Nutritional supplement
KR20120119686A (ko) Ｌ-아르기닌, 비타민ｃ, 비타민 ｂ군, 비타민ａ, 비타민ｅ 및 요오드화칼륨을 주성분으로 함유하는 기능성 음료조성물
Urankar et al. Formulation development and evaluation of cholecalciferol (vitamin D3) granules and tablets
CN105287625B (zh) 一种铝碳酸镁组合药物片剂、制备方法及其应用
JP3088707B2 (ja) 吸収抑制剤
Beaufrère et al. La nutrition iodée chez l'enfant
NEWNHAM Cracoe House Cottage, Cracoe, Skipton, North Yorkshire. BD23 6LB.
CN108969650A (zh) 一种公猪用生精粉

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17730337

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 22.08.2018)

122 Ep: pct application non-entry in european phase

Ref document number: 17730337

Country of ref document: EP

Kind code of ref document: A1